Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in pathogenesis, novel therapeutic strategies and interventions for age-related hearing loss.

Frontiers in molecular neuroscience·2026
Same author

Deep Eutectic Solvent-Mediated Engineering of Polyamide Membranes for High-Performance Loose Nanofiltration.

Polymer science & technology (Washington, D.C.)·2026
Same author

Online IR spectroscopic quantification and reaction process analysis in continuous flow system.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Dual Polyamide Thin-Film Composite Membrane With Multiscale Hetero-Channels and Mosaic Charge Architecture for Boosting Ion Transport and Osmotic Energy Conversion.

Angewandte Chemie (International ed. in English)·2026
Same author

Alterations in NK cell subsets and the regulatory role of JAB1 in nasopharyngeal carcinoma with implications for tumor immunity and biomarker development.

British journal of cancer·2026
Same author

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

Nature communications·2026

Related Experiment Video

Updated: Mar 9, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K

Gene Expression Differences in Prostate Cancers between Young and Old Men.

Yuanchun Ding1, Huiqing Wu2, Charles Warden3

  • 1Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America.

Plos Genetics
|December 28, 2016
PubMed
Summary
This summary is machine-generated.

Younger men with prostate cancer show distinct gene expression linked to inflammation and immune suppression. These findings suggest new biomarkers for early detection and treatment in early-onset prostate cancer.

More Related Videos

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

13.9K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Related Experiment Videos

Last Updated: Mar 9, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

13.9K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Prostate cancer incidence is rising in younger populations.
  • Understanding molecular differences in early-onset prostate cancer is crucial.

Purpose of the Study:

  • To compare mRNA and miRNA expression profiles in young (≤45 years) versus older (71-74 years) men diagnosed with Gleason 7 (3+4) T2 prostate cancer.
  • To identify molecular mechanisms driving early-onset prostate cancer.

Main Methods:

  • Differential gene expression analysis (DEGs) between young and older prostate cancer cohorts.
  • Pathway analysis of DEGs to identify biological processes.
  • Correlation analysis of specific gene/pathway expression with biochemical recurrence.

Main Results:

  • Identified DEGs between young and older prostate cancer cohorts.
  • Younger cohort exhibited heightened inflammatory and immune responses.
  • Upregulation of CTLA4 and IDO1/TDO2 pathways observed in young cohort tumors.
  • Overexpression of CTLA4 and IDO1 correlated with biochemical recurrence.

Conclusions:

  • Inflammation and immune suppression may play a significant role in early-onset prostate cancer development.
  • CTLA4 and IDO1 pathways represent potential therapeutic targets.
  • Identified potential biomarkers for early detection and treatment of prostate cancer in young men.